Hybrid Open-endovascular Repair for Thoracoabdominal Aortic Aneurysms: Current Status and Level of Evidence

• Published in: European journal of vascular and endovascular surgery 2007-11, Vol.34 (5), p.528-533
• Main Authors: Donas, K.P, Czerny, M, Guber, I, Teufelsbauer, H, Nanobachvili, J
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aneurysm, Ruptured - surgery; Aortic Aneurysm, Abdominal - surgery; Aortic Aneurysm, Thoracic - surgery; Blood Vessel Prosthesis Implantation; Female; Humans; Hybrid; Male; Middle Aged; Open-endovascular repair; Stents; Surgery; Systematic review; Thoraco-abdominal aortic aneurysm; Treatment Outcome; Vascular Patency
• ISSN: 1078-5884; 1532-2165
• DOI: 10.1016/j.ejvs.2007.05.023

Purpose To report the results of a systematic review of the literature and to provide evidence for the hybrid open-endovascular repair (HOER) in patients with thoracoabdominal aortic aneurysms (TAAAs). Methods A comprehensive literature review was performed and all studies identified that reported the results of HOER in patients with TAAA and information about primary technical and clinical success in evaluating the immediate and long-term complications such as neurological, renal and respiratory morbidity. All studies were reviewed by two independent observers for the above mentioned parameters. Results After careful selection according to the given criteria, 13 studies were included in our statistical analysis. The number of reported patients totalled 58. Of those, 37 were men (64.4%) and the mean age of the patients was 68.1 years (range 35–80, 95%CI [72.8, 64.9]). All patients were unfit for open repair with severe comorbidities. The mean follow-up period was 14.5 +/− 8.7 months (range 4–36, 95%CI [18.7, 9.9]) and the mean aneurysm diameter was 7.15 cm (range 5 to 12, 95%CI [7.87, 6.69]). 229 (97.8%) of the 234 visceral vessel grafts remained patent during the follow-up period. Reintervention was necessary in one (1.6%) of the five patients with an occluded graft. The overall long-term endoleak rate was 20.6% (12/58 patients) and the reintervention rate was 13.7% (8/58 patients). No patients developed procedure-related neurological deficits. The overall early and long-term mortality rate for completed procedures was 15.5% (9/58). Conclusions HOER shows promising mid-term results for high-risk patients who have TAAA, however, present evidence does not allow robust conclusions.